← All peptidesPDA-V1 attestation Citations
warningBioGate · AMBERGrade B
Substance P
RPKPQQFFGLMUndecapeptide tachykinin; primary NK1 receptor agonist driving nociception, vasodilation, and neurogenic inflammation. NK1 antagonists (aprepitant) approved for chemo-induced nausea.
amidated C-terminustachykinin family
MW
1347.63
Length
11aa
Posterior
71.3%
Structural preview · ESMFold-2 mockdeterministic per sequence
Backbone preview · amidated C-terminus
Cryptographic chain of custody.
- Outer PDA hash
- Inputs hash
- Merkle root
- TEE attestation
- Protocol version
- PDA-V1
- Source
- peptide-md
- Model version
- structure-fm-2026.04
- Candidates emitted
- 2
- Signed
- 2026-04-21T08:14:33Z
Verifiable in your browser at /verifier with
@peptide-md/verifier.Real-world evidence
Cohort-attested outcomes.
Cohorts
1
Participants
76
Mean Δ
+5.56
Δ HRV ms (8-week) · 95% CI [4.1, 7.02]
IPNFT - Not minted
This peptide is not currently represented as an IPNFT. Cohort outcomes feed back into the unminted pool.
Source literature.
Grade A1993 · Physiol Rev
Neurotransmitter functions of mammalian tachykinins
Otsuka M, Yoshioka K.